SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kenneth M Dürsteler, Marc Vogel, Effective drug therapy for cocaine dependence: a milestone, The Lancet, 2016,

    CrossRef

  2. 2
    M. Underner, J. Perriot, G. Peiffer, J.-C. Meurice, Effets de l’activité physique sur le syndrome de sevrage et le craving à l’arrêt du tabac, Revue des Maladies Respiratoires, 2016,

    CrossRef

  3. 3
    Gail D. Anderson, Lingtak-Neander Chan, Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products, Clinical Pharmacokinetics, 2016,

    CrossRef

  4. 4
    Andrea R. Masters, Michael McCoy, David R. Jones, Zeruesenay Desta, Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC–MS/MS, Journal of Chromatography B, 2016, 1015-1016, 201

    CrossRef

  5. 5
    Francisco Pastor Pascual, Julio Fontoba Ferrándiz, María Carmen Gil Sanchez, Francisco Ponce Lorenzo, Carlos Botella Estrella, Two-Year Therapeutic Effectiveness of Varenicline for Smoking Cessation in a Real World Setting, Substance Use & Misuse, 2016, 51, 2, 131

    CrossRef

  6. 6
    Boris B. Quednow, Marcus Herdener, Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions, 2016,

    CrossRef

  7. 7
    Jonathan W. Lockner, Jenny M. Lively, Karen C. Collins, Janaína C. M. Vendruscolo, Marc R. Azar, Kim D. Janda, A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity, Journal of Medicinal Chemistry, 2015, 58, 2, 1005

    CrossRef

  8. 8
    Lieven Annemans, Sophie Marbaix, Kristiaan Nackaerts, Pierre Bartsch, Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation, Preventive Medicine Reports, 2015, 2, 189

    CrossRef

  9. 9
    Fabricio A. Moreira, Jeffrey W. Dalley, Dopamine receptor partial agonists and addiction, European Journal of Pharmacology, 2015, 752, 112

    CrossRef

  10. 10
    M. Underner, J. Perriot, G. Peiffer, J.-C. Meurice, Efficacité de l’activité physique dans l’aide à l’arrêt du tabac, Revue des Maladies Respiratoires, 2015, 32, 10, 1016

    CrossRef

  11. 11
    Henri-Jean Aubin, Amandine Luquiens, Feeding Two Birds with One Scone: The Case of Varenicline, Alcoholism: Clinical and Experimental Research, 2015, 39, 12
  12. 12
    Joanne Shirine Allam, Christopher D. Ochoa, Pharmacological therapies in smoking cessation: an evidence-based update, Current Pulmonology Reports, 2015, 4, 4, 173

    CrossRef

  13. 13
    Rosario Wippold, Maher Karam-Hage, Janice Blalock, Paul Cinciripini, Selection of Optimal Tobacco Cessation Medication Treatment in Patients With Cancer, Clinical Journal of Oncology Nursing, 2015, 19, 2, 170

    CrossRef

  14. 14
    Andrea L. Malizia, Albert Ferro, Drugs for addiction: a therapeutic area in need of a ‘shot in the arm’, British Journal of Clinical Pharmacology, 2014, 77, 2
  15. 15
    Nicole E De Long, Nicole G Barra, Daniel B Hardy, Alison C Holloway, Is it safe to use smoking cessation therapeutics during pregnancy?, Expert Opinion on Drug Safety, 2014, 13, 12, 1721

    CrossRef